Paper34945781
Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin.
Fiorillo A and 3 others. J Pers Med, 2021. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin. Papers, record 34945781. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34945781
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FISR2019_03796 | Ministero dell'Università e della Ricerca | PubMed | ||
| PRIN 2017 | Ministero dell'Istruzione, dell'Università e della Ricerca | PubMed | ||
| B56G15001140005 | CNCCS | PubMed |
Source PubMed
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29620053 | Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities. | Acta Pharmacol Sin | 2018 | https://conductscience.org/library/papers/29620053 | PubMed |
| 2 | 23266961 | Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. | Mol Cell Proteomics | 2013 | https://conductscience.org/library/papers/23266961 | PubMed |
| 3 | 29366651 | Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative. | Bioorg Med Chem Lett | 2018 | https://conductscience.org/library/papers/29366651 | PubMed |
| 4 | 32050486 | Expanding Role of Ubiquitin in Translational Control. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32050486 | PubMed |
| 5 | 22123826 | A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22123826 | PubMed |
| 6 | 30243861 | Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis. | Lancet Neurol | 2018 | https://conductscience.org/library/papers/30243861 | PubMed |
| 7 | 23000965 | Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. | Nat Cell Biol | 2012 | https://conductscience.org/library/papers/23000965 | PubMed |
| 8 | 8159192 | A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. | N Engl J Med | 1994 | https://conductscience.org/library/papers/8159192 | PubMed |
| 9 | 17141218 | Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin. | Exp Cell Res | 2007 | https://conductscience.org/library/papers/17141218 | PubMed |
| 10 | 23201676 | Ubiquitin chain conformation regulates recognition and activity of interacting proteins. | Nature | 2012 | https://conductscience.org/library/papers/23201676 | PubMed |
| 11 | 10966114 | Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. | Cell | 2000 | https://conductscience.org/library/papers/10966114 | PubMed |
| 12 | 26363003 | Regulation of the human ether-a-go-go-related gene (hERG) potassium channel by Nedd4 family interacting proteins (Ndfips). | Biochem J | 2015 | https://conductscience.org/library/papers/26363003 | PubMed |
| 13 | 25043012 | Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. | Nature | 2014 | https://conductscience.org/library/papers/25043012 | PubMed |
| 14 | 24516159 | HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24516159 | PubMed |
| 15 | 25009276 | Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits. | J Neurosci | 2014 | https://conductscience.org/library/papers/25009276 | PubMed |
| 16 | 31767406 | Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteins. | Bioorg Med Chem | 2020 | https://conductscience.org/library/papers/31767406 | PubMed |
| 17 | 31580635 | Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins. | ACS Chem Biol | 2019 | https://conductscience.org/library/papers/31580635 | PubMed |
| 18 | 31968243 | Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival. | Cell Rep | 2020 | https://conductscience.org/library/papers/31968243 | PubMed |
| 19 | 20354076 | Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. | Hum Mol Genet | 2010 | https://conductscience.org/library/papers/20354076 | PubMed |
| 20 | 24151181 | Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. | Mov Disord | 2014 | https://conductscience.org/library/papers/24151181 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41837791 | Ubiquitin signatures on aggregating proteins in neurodegeneration. | Essays Biochem | 2025 | https://conductscience.org/library/papers/41837791 | PubMed |
| 41528540 | Molecular Mechanisms and Therapeutic Potential of Degron-Mediated Proteostasis Regulation in Neurodegenerative Diseases. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41528540 | PubMed |
| 41303392 | Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington's Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303392 | PubMed |
| 41264052 | The Ubiquitin-Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers. | J Neuroimmune Pharmacol | 2025 | https://conductscience.org/library/papers/41264052 | PubMed |
| 41250614 | Benchmarking In-Cell Proteomics for Profiling Neuroblastoma Cell Differentiation and the Ubiquitin-Proteasome System. | J Proteome Res | 2025 | https://conductscience.org/library/papers/41250614 | PubMed |
| 40663606 | NEDD4L induces mitochondrial dysfunction and neurodegeneration by promoting LIPT2 degradation in Huntington's disease. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40663606 | PubMed |
| 39449505 | UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting. | Neurol Int | 2024 | https://conductscience.org/library/papers/39449505 | PubMed |
| 39105197 | Protein modification in neurodegenerative diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39105197 | PubMed |
| 39062952 | Gastrodin Improves the Activity of the Ubiquitin-Proteasome System and the Autophagy-Lysosome Pathway to Degrade Mutant Huntingtin. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062952 | PubMed |
| 38685916 | Targeted protein degradation in CNS disorders: a promising route to novel therapeutics? | Front Mol Neurosci | 2024 | https://conductscience.org/library/papers/38685916 | PubMed |
| 36536188 | An overview of PROTACs: a promising drug discovery paradigm. | Mol Biomed | 2022 | https://conductscience.org/library/papers/36536188 | PubMed |
| 35871359 | Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease. | J Huntingtons Dis | 2022 | https://conductscience.org/library/papers/35871359 | PubMed |
Genes75
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34945781
GET https://conductscience.org/api/papers/v1/34945781/references?page=2